Click on image to view larger version.

Figure 1 One-year survival free from major adverse cardiac events (MACE) of patients with intermediate lesions randomized to drug-eluting stents (DES) versus bare-metal stents (BMS). MI = myocardial infarction; TVR = target vessel revascularization.